A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Clinical trial NCT01123785 · COMPLETED
Trial details
- NCT number
- NCT01123785
- Sponsor
- Inotek Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.